SiNtx Technologies (SINT) Stock: Buy, Sell, or Hold?
SINT - SiNtx Technologies, Inc. Common Stock
$1.80
-0.06 (-3.23%)
▼
5d:
+16.88%
30d:
+14.65%
90d:
-18.55%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SINT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SINT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SINT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SINT is currently trading at $1.80, which is considered extended relative to its 30-day fair value range of $1.52 to $1.73.
Technical Outlook: Technically, SINT is in a strong downtrend. Immediate support is located at $1.46, while resistance sits at $1.94. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: SINT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.12 (+406.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SINT is in a strong downtrend. Immediate support is located at $1.46, while resistance sits at $1.94. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: SINT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.12 (+406.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.52 -
$1.73
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 406.9% below Wall St target ($9.12)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.52 -
$1.73
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.46
Resistance Level
$1.94
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.39
Wall Street Target
$9.13
(+406.9%)
Revenue Growth (YoY)
199.3%
Share & Embed Analysis
Last updated: September 13, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SINT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$62 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
